Enhancing Epilepsy Management With Precision Deep Brain Stimulation

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions
Epilepsy, Drug Resistant
Interventions
DEVICE

Neuromodulation programming

"Participants will be brought in for their standard follow-up appointments at 4-weeks, 4-months, and 1-year post-surgery. In addition to the routine care, physiological data will be extracted from the implanted device and analyzed. The physiological data will be considered along with the standard epilepsy diary to assess epileptic burden and inform device programming.~Quality of life will be measured with a series of standard questionnaires pre-surgery and at the 1-year follow-up."

Trial Locations (1)

B3H 3A7

Queen Elizabeth Health Science Centre, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

NCT06364085 - Enhancing Epilepsy Management With Precision Deep Brain Stimulation | Biotech Hunter | Biotech Hunter